GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lincoln Pharmaceuticals Ltd (NSE:LINCOLN) » Definitions » E10

Lincoln Pharmaceuticals (NSE:LINCOLN) E10 : ₹34.31 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Lincoln Pharmaceuticals E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Lincoln Pharmaceuticals's adjusted earnings per share data for the three months ended in Dec. 2024 was ₹10.370. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹34.31 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Lincoln Pharmaceuticals's average E10 Growth Rate was 14.00% per year. During the past 3 years, the average E10 Growth Rate was 15.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Lincoln Pharmaceuticals was 15.90% per year. The lowest was 15.90% per year. And the median was 15.90% per year.

As of today (2025-04-11), Lincoln Pharmaceuticals's current stock price is ₹536.25. Lincoln Pharmaceuticals's E10 for the quarter that ended in Dec. 2024 was ₹34.31. Lincoln Pharmaceuticals's Shiller PE Ratio of today is 15.63.

During the past 13 years, the highest Shiller PE Ratio of Lincoln Pharmaceuticals was 27.76. The lowest was 11.48. And the median was 15.99.


Lincoln Pharmaceuticals E10 Historical Data

The historical data trend for Lincoln Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lincoln Pharmaceuticals E10 Chart

Lincoln Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 18.94 22.30 26.31 30.99

Lincoln Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.10 30.99 32.41 33.44 34.31

Competitive Comparison of Lincoln Pharmaceuticals's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Lincoln Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lincoln Pharmaceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lincoln Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Lincoln Pharmaceuticals's Shiller PE Ratio falls into.


;
;

Lincoln Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lincoln Pharmaceuticals's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=10.37/158.3229*158.3229
=10.370

Current CPI (Dec. 2024) = 158.3229.

Lincoln Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201503 1.350 97.163 2.200
201506 4.010 99.841 6.359
201509 4.100 101.753 6.379
201512 3.880 102.901 5.970
201603 2.400 102.518 3.706
201606 6.990 105.961 10.444
201609 5.420 105.961 8.098
201612 3.270 105.196 4.921
201703 0.660 105.196 0.993
201706 2.460 107.109 3.636
201709 5.650 109.021 8.205
201712 5.790 109.404 8.379
201803 3.410 109.786 4.918
201806 8.030 111.317 11.421
201809 7.500 115.142 10.313
201812 4.570 115.142 6.284
201903 4.250 118.202 5.693
201906 6.330 120.880 8.291
201909 9.460 123.175 12.159
201912 5.460 126.235 6.848
202003 4.470 124.705 5.675
202006 7.630 127.000 9.512
202009 10.460 130.118 12.727
202012 6.730 130.889 8.141
202103 6.290 131.771 7.557
202106 8.840 134.084 10.438
202109 11.500 135.847 13.403
202112 8.790 138.161 10.073
202203 5.510 138.822 6.284
202206 7.490 142.347 8.331
202209 11.840 144.661 12.958
202212 10.790 145.763 11.720
202303 6.280 146.865 6.770
202306 9.490 150.280 9.998
202309 13.810 151.492 14.433
202312 14.000 152.924 14.494
202403 9.280 153.035 9.601
202406 11.820 155.789 12.012
202409 13.150 157.882 13.187
202412 10.370 158.323 10.370

Add all the adjusted EPS together and divide 10 will get our e10.


Lincoln Pharmaceuticals  (NSE:LINCOLN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Lincoln Pharmaceuticals's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=536.25/34.31
=15.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Lincoln Pharmaceuticals was 27.76. The lowest was 11.48. And the median was 15.99.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Lincoln Pharmaceuticals E10 Related Terms

Thank you for viewing the detailed overview of Lincoln Pharmaceuticals's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Lincoln Pharmaceuticals Business Description

Traded in Other Exchanges
Address
Science City Road, Lincoln House, Behind Satyam Complex, Sola, Ahmedabad, GJ, IND, 380060
Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of cardiac, diabetic, anti-malarial, anti-biotic, anti-fungal, cephalosporin, analgesics, anesthetics, anti-pyretic, GIT products, vitamin-minerals, and iron preparations. Some of the key brands through which the company markets its products are; Rhino, Binafin, Kezolin, Hepalin, Progut, and Vomistat among others. Geographically, it carries out sales in India and outside India; generating key revenue from outside India.

Lincoln Pharmaceuticals Headlines

No Headlines